|
|
xi | |
Woodhead Publishing Series in Biomaterials |
|
xiii | |
|
1 Biodegradable medical polymers: fundamental sciences |
|
|
1 | (34) |
|
|
|
|
|
1 | (10) |
|
1.2 Biodegradable polymer chain structures |
|
|
11 | (5) |
|
1.3 Physical properties of biodegradable polymers |
|
|
16 | (3) |
|
1.4 Biodegradable polymers in solid state |
|
|
19 | (3) |
|
1.5 Biodegradable polymers in solutions |
|
|
22 | (1) |
|
1.6 Biodegradable polymer hybrids |
|
|
23 | (1) |
|
1.7 Materials selection and design control for medical applications |
|
|
23 | (7) |
|
1.8 Summary -- key points learnt in the chapter |
|
|
30 | (5) |
|
|
30 | (5) |
|
Part One Biodegradable and bioresorbable synthetic medical polymers |
|
|
35 | (220) |
|
2 Synthetic biodegradable medical polyesters |
|
|
37 | (42) |
|
|
|
37 | (1) |
|
2.2 Synthesis methods and structure-properties |
|
|
38 | (2) |
|
2.3 Physico-chemical properties |
|
|
40 | (1) |
|
2.4 Degradation of poly(lactic acid) and poly(glycolic acid) polymers |
|
|
41 | (25) |
|
2.5 Case studies for biomedical and pharmaceutical applications |
|
|
66 | (4) |
|
|
70 | (9) |
|
|
70 | (9) |
|
3 Synthetic biodegradable medical polyesters: poly-ε-caprolactone |
|
|
79 | (28) |
|
|
|
|
|
|
79 | (2) |
|
3.2 Chemical structure and methods for producing poly-ε-caprolactone |
|
|
81 | (3) |
|
3.3 Processing techniques of poly-ε-caprolactone |
|
|
84 | (4) |
|
3.4 Mechanical properties and degradation of poly-ε-caprolactone-based biomaterials |
|
|
88 | (6) |
|
3.5 Surface functionalisation of poly-ε-caprolactone and poly-ε-caprolactone biological properties |
|
|
94 | (2) |
|
3.6 Case studies of medical applications |
|
|
96 | (1) |
|
3.7 Commercialisation and future trends of poly-ε-caprolactone-based biomaterials |
|
|
97 | (1) |
|
3.8 Summary -- key points learnt in the chapter |
|
|
98 | (9) |
|
|
99 | (1) |
|
|
99 | (8) |
|
4 Synthetic biodegradable medical polyesters: poly(trimethylene carbonate) |
|
|
107 | (46) |
|
|
|
|
|
107 | (2) |
|
4.2 Synthesis and structure--properties |
|
|
109 | (10) |
|
4.3 Degradation of poly(trimethylene carbonate) and copolymers |
|
|
119 | (16) |
|
4.4 Biomedical and pharmaceutical applications |
|
|
135 | (5) |
|
4.5 Conclusion and perspectives |
|
|
140 | (13) |
|
|
140 | (13) |
|
5 Synthetic biodegradable medical polymer: poly anhydrides |
|
|
153 | (36) |
|
|
|
|
|
|
|
153 | (2) |
|
5.2 Historical perspective |
|
|
155 | (1) |
|
5.3 Classification of polyanhydrides and chemical structures |
|
|
155 | (7) |
|
|
162 | (6) |
|
5.5 Processing techniques |
|
|
168 | (3) |
|
5.6 Degradation mechanism |
|
|
171 | (3) |
|
|
174 | (1) |
|
5.8 Medical applications of polyanhydrides |
|
|
175 | (5) |
|
|
180 | (1) |
|
|
180 | (9) |
|
|
181 | (1) |
|
|
181 | (8) |
|
6 Synthetic biodegradable medical polyurethanes |
|
|
189 | (28) |
|
|
|
|
|
|
|
|
|
|
189 | (1) |
|
6.2 Synthesis methods of polyurethanes |
|
|
190 | (5) |
|
6.3 Degradable and biocompatibile polyurethanes: selection of block constituents |
|
|
195 | (3) |
|
6.4 Main general applications of degradable polyurethanes in regenerative medicine and drug release |
|
|
198 | (12) |
|
|
210 | (1) |
|
6.6 Summary -- key points learnt in the chapter |
|
|
211 | (6) |
|
|
212 | (1) |
|
|
212 | (5) |
|
7 Synthetic biodegradable medical polymers: polymer blends |
|
|
217 | (38) |
|
|
|
|
|
217 | (1) |
|
7.2 Thermodynamics and nanophase diagram of biodegradable polymer blends |
|
|
217 | (11) |
|
7.3 Biodegradable polymer blends |
|
|
228 | (18) |
|
7.4 Case studies of medical applications |
|
|
246 | (4) |
|
|
250 | (1) |
|
7.6 Summary -- key points learnt in the chapter |
|
|
251 | (4) |
|
|
251 | (4) |
|
Part Two Biodegradable and bioresorbable natural medical polymers |
|
|
255 | (122) |
|
8 Natural bacterial biodegradable medical polymers: polyhydroxyalkanoates |
|
|
257 | (22) |
|
|
|
|
|
257 | (2) |
|
8.2 Types of polyhydroxyalkanoates and their properties |
|
|
259 | (5) |
|
8.3 Degradation of polyhydroxyalkanoates |
|
|
264 | (2) |
|
8.4 Applications of polyhydroxyalkanoates |
|
|
266 | (5) |
|
|
271 | (1) |
|
8.6 Summary -- key points learnt in the chapter |
|
|
272 | (7) |
|
|
272 | (7) |
|
9 Natural biodegradable medical polymers: cellulose |
|
|
279 | (16) |
|
|
|
|
279 | (1) |
|
9.2 Types and chemical structure of cellulose |
|
|
279 | (2) |
|
9.3 Degradation mechanisms |
|
|
281 | (4) |
|
9.4 Processing techniques |
|
|
285 | (1) |
|
9.5 Case studies: cellulose application in medical applications |
|
|
286 | (3) |
|
|
289 | (1) |
|
9.7 Summary -- key points learnt in the chapter |
|
|
289 | (6) |
|
|
290 | (5) |
|
10 Natural bacterial biodegradable medical polymers: bacterial cellulose |
|
|
295 | (26) |
|
|
|
|
295 | (1) |
|
10.2 Types and chemical structure of bacterial cellulose |
|
|
296 | (3) |
|
10.3 Processing techniques |
|
|
299 | (5) |
|
10.4 Case studies of medical applications |
|
|
304 | (6) |
|
|
310 | (1) |
|
10.6 Summary -- key points learnt in the chapter |
|
|
311 | (10) |
|
|
311 | (5) |
|
|
316 | (5) |
|
11 Natural biodegradable medical polymers: therapeutic peptides and proteins |
|
|
321 | (30) |
|
|
|
|
|
|
321 | (1) |
|
11.2 Structure and bioactive properties of food proteins/peptides |
|
|
321 | (8) |
|
11.3 Instability of proteins/peptides |
|
|
329 | (1) |
|
11.4 Oral delivery of proteins/peptides |
|
|
329 | (9) |
|
11.5 Medical applications of nisin, a food preservation additive |
|
|
338 | (1) |
|
|
339 | (1) |
|
11.7 Summary -- key points learnt in the chapter |
|
|
340 | (11) |
|
|
340 | (11) |
|
12 Natural biodegradable medical polymers: silk |
|
|
351 | (26) |
|
|
|
|
351 | (1) |
|
12.2 Types and chemical structure of silk |
|
|
352 | (3) |
|
12.3 Processing techniques of silk |
|
|
355 | (3) |
|
12.4 Mechanical properties |
|
|
358 | (2) |
|
12.5 Degradation mechanisms |
|
|
360 | (2) |
|
12.6 Medical applications |
|
|
362 | (3) |
|
|
365 | (1) |
|
12.8 Summary -- key points learnt in the chapter |
|
|
366 | (11) |
|
|
367 | (10) |
|
Part Three Properties of biodegradable medical polymers |
|
|
377 | (72) |
|
13 Biocompatibility of biodegradable medical polymers |
|
|
379 | (36) |
|
|
|
|
|
13.1 Introduction: definitions of biocompatibility |
|
|
379 | (1) |
|
13.2 Chemical compatibility |
|
|
380 | (4) |
|
13.3 Mechanical compatibility |
|
|
384 | (3) |
|
13.4 Interactions between degradable polymers and biological systems |
|
|
387 | (5) |
|
13.5 Design principles to ensure biocompatibility for medical applications |
|
|
392 | (9) |
|
13.6 Summary -- key points learnt in the chapter |
|
|
401 | (14) |
|
|
402 | (13) |
|
14 Degradation characterisation of biodegradable polymers |
|
|
415 | (12) |
|
|
|
|
415 | (1) |
|
14.2 In vitro characterisation of degradation studies |
|
|
415 | (2) |
|
14.3 Effect of isotope on degradation rate |
|
|
417 | (1) |
|
14.4 New imaging technology for degradation studies |
|
|
417 | (4) |
|
14.5 Mechanical characterisation |
|
|
421 | (3) |
|
14.6 Summary -- key points learnt in the chapter |
|
|
424 | (3) |
|
|
424 | (3) |
|
15 Modelling degradation of biodegradable polymers |
|
|
427 | (22) |
|
|
|
|
427 | (1) |
|
15.2 Diffusion kinetics -- Fick's law and water diffusion modelling |
|
|
427 | (5) |
|
15.3 Computer modelling of polymer degradation |
|
|
432 | (13) |
|
15.4 Computer modelling of the mechanical property change during biodegradation |
|
|
445 | (2) |
|
15.5 Summary -- key points learnt in the chapter |
|
|
447 | (2) |
|
|
447 | (2) |
Index |
|
449 | |